In prostate cancer, it reduces proliferation, invasion, and migration by targeting DLX1 and IGF-1R, while sponging by oncogenic lncRNAs such as SNHG11 and MYU relieves inhibition of c-MYC, highlighting its suppressive role [9, 18, 44]. The gene discussed is VPS9D1-AS1; the disease is prostate carcinoma.